News | September 22, 2023
Glenmark Pharma to sell 75% stake in Glenmark Life Sciences to Nirma for Rs. 5,652 Cr
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
The partnership is part of BioNTech’s strategy to develop novel prophylactic vaccines for the prevention of high-medical-need infectious diseases
The market capitalization of the company stood at Rs. 7,000 crore +
Luran S MED 797S SPF30 is one of the first ASA materials in the market specifically for medical device housings
The complexity of operating on a one-year-old are many with the organs being tiny, fragile
The partnership acknowledges the increasing mental health challenges faced by students in today's society
This X-ray device is not only low-dose but also lightweight, making it the perfect tool for quick & accurate diagnoses
CureVac is among many pharmaceutical companies looking to produce a novel seasonal influenza vaccine via mRNA technology
Approval is for use in myelofibrosis patients with anaemia regardless of prior myelofibrosis therapy
Subscribe To Our Newsletter & Stay Updated
